A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer

Clinical trial NCT05769764 · COMPLETED

Trial details

NCT number: NCT05769764
Sponsor: Daiichi Sankyo
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2022-12-19
Primary completion: 2023-04-06
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.